3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
12
Burkitt Lymphoma
8
Lymphoma, Follicular
7
Sarcoma
5
Lymphoma, Non-Hodgkin
5
Hodgkin Disease
5
Neoplasms
4
Lymphoma
4
Wilms Tumor
3
Sarcoma, Ewing
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Osteosarcoma
3
Lymphoma, B-Cell
3
Liposarcoma
3
Endometrial Neoplasms
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Plasmablastic Lymphoma
2
Ovarian Neoplasms
2
Multiple Myeloma
2
Lymphoproliferative Disorders
2
Lymphoma, T-Cell
2
Lymphoma, Mantle-Cell
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Ganglioneuroblastoma
2
Fallopian Tube Neoplasms
2
Down Syndrome
2
Dermatofibrosarcoma
2
Interventions
Oxaliplatin
9
Leucovorin
8
Fluorouracil
8
Bevacizumab
6
Cetuximab
5
Specimen Handling
4
fludarabine
3
Pemetrexed
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Cyclophosphamide
3
pembrolizumab
2
encorafenib
2
dehydroftorafur
2
aldesleukin
2
Irinotecan
2
Immunoglobulin G
2
Gemcitabine
2
Folfox protocol
2
Disulfides
2
Cisplatin
2
Celecoxib
2
Carboplatin
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
temsirolimus
1
sapanisertib
1
repotrectinib
1
relatlimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Doxorubicin
×
30 days
×
Clear all
No trials found.